AIA Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

AIA Group’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,630	Closed	-$1.15M	–	349
2023 Q4	$1.15M	Buy	+3,630	New	+$706K	0.05%	187

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

AIA Group's KRTX Position: Q1 2024 in Review

AIA Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,630 shares — an estimated $1.15M sold.

AIA Group first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.15M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

AIA Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AIA Group sold 3,630 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.15M.
AIA Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
AIA Group's Karuna Therapeutics, Inc. Common Stock position peaked at $1.15M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on AIA Group's 13F filing for Q1 2024, filed 6 May 2024.